Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Wooldridge

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ochsner Journal|March 23, 2012
Bariatric surgery significantly improves body proportionThomas Kang, James Wooldridge, Laura Periou, et al.
Journal of Nephrology|September 17, 2004
Solitary liver mass causing diagnostic dilemma in a case of lupus nephritisMadhukar Misra, Boris W Kuvshinoff, James Wooldridge, et al.
The American Surgeon|November 5, 2009
Minimally invasive esophagectomy without the use of postoperative nasogastric tube decompressionNinh T Nguyen, Johnathan Slone, James Wooldridge, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|August 24, 2023
A Single-Institution 5-Year Retrospective Analysis of Laparoscopic Sleeve Gastrectomy Staple-Line Reinforcement: Bioabsorbable Mesh Versus OversewingJesse St Pierre, H Harvak Hajebian, Cruz Velasco, et al.
Surgical Endoscopy|July 30, 2024
The SAGES masters program presents the 10 seminal articles for laparoscopic sleeve gastrectomyJudy Y Chen, Sajani Shah, S Julie-Ann Lloyd, et al.
Blood|November 16, 2007
Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 studyBertrand Coiffier, Stéphane Lepretre, Lars Møller Pedersen, et al.
British Journal of Haematology|April 23, 2010
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 studyBertrand Coiffier, Nedjad Losic, Birgitte Biilmann Rønn, et al.
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ochsner Journal|March 23, 2012
Bariatric surgery significantly improves body proportionThomas Kang, James Wooldridge, Laura Periou, et al.
Journal of Nephrology|September 17, 2004
Solitary liver mass causing diagnostic dilemma in a case of lupus nephritisMadhukar Misra, Boris W Kuvshinoff, James Wooldridge, et al.
The American Surgeon|November 5, 2009
Minimally invasive esophagectomy without the use of postoperative nasogastric tube decompressionNinh T Nguyen, Johnathan Slone, James Wooldridge, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|August 24, 2023
A Single-Institution 5-Year Retrospective Analysis of Laparoscopic Sleeve Gastrectomy Staple-Line Reinforcement: Bioabsorbable Mesh Versus OversewingJesse St Pierre, H Harvak Hajebian, Cruz Velasco, et al.
Surgical Endoscopy|July 30, 2024
The SAGES masters program presents the 10 seminal articles for laparoscopic sleeve gastrectomyJudy Y Chen, Sajani Shah, S Julie-Ann Lloyd, et al.
Blood|November 16, 2007
Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 studyBertrand Coiffier, Stéphane Lepretre, Lars Møller Pedersen, et al.
British Journal of Haematology|April 23, 2010
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 studyBertrand Coiffier, Nedjad Losic, Birgitte Biilmann Rønn, et al.
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Pageof 1